Terumo Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "End-Period-Cash-Flow" stands at 855.88 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Terumo Corp.'s second quarter result of 217.16 Billion JPY for the item "End Period Cash Flow" represents an increase of 6.30 percent compared to it's first quarter result.
Also, Terumo Corp.'s second quarter result of 217.16 Billion JPY for the item "End Period Cash Flow" represents an increase of 11.41 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Terumo Corp.'s second quarter result of 855.88 Billion JPY for the item "End Period Cash Flow" represents an increase of 2.67 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.86 percent compared to the value the year prior.
The 1 year change in percent is 12.86.
The 3 year change in percent is 2.84.
The 5 year change in percent is 22.02.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - End Period Cash Flow | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - End Period Cash Flow | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - End Period Cash Flow | 172,241,486,586.05 |
![]() | Danaher Corporation - End Period Cash Flow | 162,006,663,168.00 |
![]() | Boston Scientific Corp - End Period Cash Flow | 144,567,730,176.00 |